Baillie Gifford acquired 49 Charles River Laboratories International shares worth $6.93 Thousand. That's 0.00% of their equity portfolio (250th largest holding). The first Charles River Laboratories International trade was made in Q2 2022. Since then Baillie Gifford bought shares five more times and sold shares on six occasions. The investor's estimated purchase price is $10.8 Thousand, resulting in a loss of 36%.